Filter Results:
(176)
Show Results For
- All HBS Web
(176)
- People (1)
- News (50)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
Show Results For
- All HBS Web
(176)
- People (1)
- News (50)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
- 22 Mar 2022
- News
Clubs Mark a Milestone and the Lunar New Year
these virtual events included Moderna Therapeutics CEO Stefan Bancel (MBA 2000), JPMorgan Chase CEO Jamie Dimon (MBA 1982), and the president and CEO of Amazon, Andy Jassy (MBA 1997). “We’ve all worked together to be able to provide... View Details
Keywords: Margie Kelley
- 11 Jun 2018
- Blog Post
Meet the 2018-2019 Blavatnik Fellows in Life Science Entrepreneurship
promising DMD treatments. While at business school, he worked to scale his nonprofit, Terry’s Foundation for Muscular Dystrophy, and helped advance therapeutics in the academic lab while raising awareness for DMD. Liz Kwo (MD/MBA 2011,... View Details
- 01 Jun 2000
- News
Managing the Map
Health (NIH) undertook the Human Genome Project, an effort to map the extraordinarily intricate chemical composition of the human genome. Scientists have long believed that understanding the vast genetic code underlying all human life will enable the development of new... View Details
Keywords: Peter K. Jacobs
- 01 Jun 2016
- News
Up by the Roots
deciding to stay for good. Long-heralded for its therapeutic applications, the global market for the bitter root was on the rise, driven by the expansion of the Chinese middle class; today, genuine Wisconsin ginseng can fetch $200 a pound... View Details
Keywords: Francis Storrs
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
communicating appropriately to maximize the therapeutic effects. The electrodes are placed inside the brain at the precise spot where the issue originates and communicate to a wireless monitor that tracks the neurotransmitter changes to... View Details
Keywords: Janelle Nanos
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
Kristina Wang (MBA 2020) is an MBA student at HBS who just completed her first year and is currently interning at Denali Therapeutics before her second year. I did not expect myself to become interested in biotechnology. Growing up in... View Details
- Web
Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement
firms like Moderna and Lexeo Therapeutics to diving into the complexities of U.S. healthcare strategy, each course reshaped my perspective. But it was Innovating in Healthcare that truly stood out. The class not only allowed me to dream... View Details
- 01 Oct 2021
- News
New Biotech Joint Degree Program Kicks Off
Frontiers in Therapeutics is an ethics and management course on the world’s most pressing unsolved medical challenges. The impetus for the program came from recognizing that the biotech sector needs strong, ethical leaders who can break... View Details
- 25 Feb 2021
- News
Building Hope
a doctor’s office for a dose of ketamine and remains under the care of medical professionals for about an hour while the ketamine does its thing. Ketamine can induce out-of-body experiences, so a safe setting is an important part of the View Details
Keywords: Daniel Morrell
- 24 Jan 2017
- First Look
First Look at New Research: January 24, 2017
Business School Case 617-029 Anthony Starks at InSiL Therapeutics (A) When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a... View Details
Keywords: Sean Silverthorne
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
positioning KiraGen Bio to create substantial value for all stakeholders. Stephen Linderman (MD, PhD 2019) is the CEO and co-founder of Absco Therapeutics (AbscoTx), an immune oncology company specializing in image-guided, intratumoral... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
ask their scientists about therapeutics they are developing as their companies grapple with both clinical trial successes and failures. Classes also will focus on the most promising advances, including CRISPR-Cas9, base editing, RNA... View Details
Keywords: Jennifer Gillespie
- 18 Nov 2014
- First Look
First Look: November 18
the continuing battle affect management, talent, and the company's financial performance? Purchase this case: https://hbr.org/product/Turkcell/an/715009-PDF-ENG Harvard Business School Case 615-024 Pfizer's Centers for Therapeutic... View Details
Keywords: Sean Silverthorne
- 01 Dec 2017
- News
Yoga Inc.
was more physical. A former triathlete, he was invited by his investment firm’s partners to a hot yoga class. “I could not believe how I felt afterward,” he recalls. “That halo effect after a good sweat—it opened up my chest, and I got the entire View Details
Keywords: Deborah Halber
- 13 May 2002
- Book
Bringing the Master Passions to Work
stand ever in need of repression, suppression, or the therapeutic influence of reason. What we cannot explain must often remain hidden. Hence, the student of passions should take the stance of a detective or a spy, seeking to expose the... View Details
Keywords: by Mihnea C. Moldoveanu & Nitin Nohria
- 30 Sep 2014
- News
Life Lessons on the Open Seas
love, instantly,” he recalls. His passion for the water prompted him to start training to sail competitively—and to leave his job in wealth management at Goldman Sachs in order to skipper his first therapeutic sail, for eight disabled... View Details
Keywords: Jill Radsken
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
from other firms, rather than developing new projects internally. Examining the channels behind this increase in R&D in-licensing, we explore heterogeneity in treatment effects and competitor spillovers. We find that competitors move resources away from affected... View Details
Keywords: Dina Gerdeman
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
is a devastating disease that leaves cognitive abilities intact, but robs people of their ability to move, essentially making them prisoners in their own bodies,” Blum says. “The therapeutic hypothesis with tirasemtiv relates to slowing... View Details
Keywords: Deborah Blagg
- 01 Dec 2022
- News
Road to Recovery
digital therapeutics (app-based programs designed to improve health outcomes), he did not fully appreciate the bureaucratic hurdles the company would face. Developing the technology and processes to administer a contingency management... View Details
- 01 Dec 2020
- News
AI Enhances Diagnostic Care
musculoskeletal diseases. Theranostics, a combination of diagnostic and therapeutic approaches to health care delivery, is a new and exciting field of nuclear medicine now offered at MRC, Tantawy says. “It’s a personalized, highly... View Details
Keywords: Jennifer Gillespie